Switch to:
Repros Therapeutics Inc (NAS:RPRX)
EV/EBITDA
-1.44 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Repros Therapeutics Inc's enterprise value is $28.16 Mil. Repros Therapeutics Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2016 was $-19.56 Mil. Therefore, Repros Therapeutics Inc's EV/EBITDA ratio for today is -1.44.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Repros Therapeutics Inc's stock price is $1.51. Repros Therapeutics Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2016 was $-0.81. Therefore, Repros Therapeutics Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Repros Therapeutics Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=28.160/-19.557
=-1.44

Repros Therapeutics Inc's current Enterprise Value is $28.16 Mil.
Repros Therapeutics Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2016 was -6.268 (Dec. 2015 ) + -4.842 (Mar. 2016 ) + -4.279 (Jun. 2016 ) + -4.168 (Sep. 2016 ) = $-19.56 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Repros Therapeutics Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=1.51/-0.81
=

Repros Therapeutics Inc's share price for today is $1.51.
Repros Therapeutics Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was -0.26 (Dec. 2015 ) + -0.2 (Mar. 2016 ) + -0.18 (Jun. 2016 ) + -0.17 (Sep. 2016 ) = $-0.81.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Repros Therapeutics Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -8.65-6.45-5.63-0.68-5.17-4.44-13.06-12.21-6.02-0.28

Repros Therapeutics Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2ebitda -10.82-5.60-6.02-5.30-4.52-5.09-0.28-0.30-1.21-2.15
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK